Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Puma Biotechnology Inc - Common Stock
(NQ:
PBYI
)
6.110
+0.000 (+0.00%)
Streaming Delayed Price
Updated: 10:06 AM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puma Biotechnology Inc - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
↗
March 19, 2024
Via
Benzinga
Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
Earnings Scheduled For February 29, 2024
↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 27, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
February 22, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
Earnings Scheduled For August 3, 2023
↗
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
February 15, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 14, 2024
Via
Benzinga
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
February 13, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
3 small-cap biotechs with potential breakthroughs in 2024
February 06, 2024
These small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024.
Via
MarketBeat
Topics
Bankruptcy
3 Strong Buy Stocks Under $5: January 2024
↗
January 31, 2024
A strong buy rating carries weight which speculative investors may want to research in these strong buy stocks under $5.
Via
InvestorPlace
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
January 11, 2024
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
December 11, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
November 06, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results
October 19, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting
October 14, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the Treatment of Small Cell Lung Cancer
September 21, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer
August 08, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Second Quarter Financial Results
August 03, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 24, 2023
Via
Benzinga
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2023 Financial Results
July 20, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
↗
July 20, 2023
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 20, 2023
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!
Via
InvestorPlace
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting
June 04, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2023
From
Puma Biotechnology, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 05, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
